Literature DB >> 7780961

Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate.

S Koop1, I C MacDonald, K Luzzi, E E Schmidt, V L Morris, M Grattan, R Khokha, A F Chambers, A C Groom.   

Abstract

Metastasis is an inefficient process; only a few cancer cells are able to form tumors after being released into the circulation. We studied the fate of cancer cells after injection into the circulation, quantifying their survival and ability to extravasate by 1 day later. B16F10 cells, parental or transfectants overexpressing tissue inhibitor of metalloproteinases 1, were injected i.v. into chorioallantoic membrane of chick embryos and analyzed by intravital videomicroscopy. Cell survival was quantified in two ways: (a) 15-microns microspheres were injected with cancer cells, and proportions of viable cells to microspheres were compared before and after injection; and (b) individual cancer cells were monitored continuously for 0.5-8-h intervals covering the first 24 h. Both methods showed virtually no destruction of cells. Greater than 80% of injected cells survived and extravasated by 24 h, indicating that growth after extravasation is a key stage of metastatic control.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780961

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

1.  Multi-organ metastatic capability of Chinese hamster ovary cells revealed by green fluorescent protein (GFP) expression.

Authors:  M Yang; T Chishima; X Wang; E Baranov; H Shimada; A R Moossa; R M Hoffman
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Governing step of metastasis visualized in vitro.

Authors:  T Chishima; M Yang; Y Miyagi; L Li; Y Tan; E Baranov; H Shimada; A R Moossa; S Penman; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems.

Authors:  M Cecilia Subauste; Tatyana A Kupriyanova; Erin M Conn; Veronica C Ardi; James P Quigley; Elena I Deryugina
Journal:  Clin Exp Metastasis       Date:  2009-10-20       Impact factor: 5.150

4.  Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well.

Authors:  S Koop; E E Schmidt; I C MacDonald; V L Morris; R Khokha; M Grattan; J Leone; A F Chambers; A C Groom
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

5.  Vascular endothelial growth factor enhances cancer cell adhesion to microvascular endothelium in vivo.

Authors:  Shang Shen; Jie Fan; Bin Cai; Yonggang Lv; Min Zeng; Yanyan Hao; Filippo G Giancotti; Bingmei M Fu
Journal:  Exp Physiol       Date:  2009-10-30       Impact factor: 2.969

6.  Establishment of a human multiple myeloma xenograft model in the chicken to study tumor growth, invasion and angiogenesis.

Authors:  Agnieszka Martowicz; Johann Kern; Eberhard Gunsilius; Gerold Untergasser
Journal:  J Vis Exp       Date:  2015-05-01       Impact factor: 1.355

7.  Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential.

Authors:  Kerstin Schlüter; Peter Gassmann; Andreas Enns; Timo Korb; Andre Hemping-Bovenkerk; Jens Hölzen; Jörg Haier
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 8.  Clinical potential of matrix metalloprotease inhibitors in cancer therapy.

Authors:  E I Heath; L B Grochow
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

9.  Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.

Authors:  Yvonne L Chao; Christopher R Shepard; Alan Wells
Journal:  Mol Cancer       Date:  2010-07-07       Impact factor: 27.401

Review 10.  Steps in tumor metastasis: new concepts from intravital videomicroscopy.

Authors:  A F Chambers; I C MacDonald; E E Schmidt; S Koop; V L Morris; R Khokha; A C Groom
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.